Targeting xCT-mediated amino acid metabolism: A novel mechanism of silymarin in ameliorating MAFLD-associated ferroptosis

Key Points

• Silymarin effectively mitigates ferroptosis in MAFLD, indicating its potential therapeutic role.
• XCT-mediated amino acid metabolism is a crucial pathway influenced by silymarin.
• The study emphasizes the importance of targeting metabolic pathways to address liver health.
• Further investigation into silymarin's efficacy may lead to new treatment strategies for MAFLD.